$4450
$3560
The In Vitro lung models market size is projected to reach US$ 1,530.11 million by 2031 from US$ 446.35 million in 2024. The market is estimated to register a CAGR of 19.4% during 2025–2031. Applications of 3D cultures and AI in oncology are likely to bring new trends to the market in the coming years.
In Vitro Lung Models Market Analysis
The market growth is driven by the surging prevalence of respiratory diseases and the rising adoption of in vitro models as an alternative to animal testing. Precision-cut lung slices (PCLS) allow the study of airway constriction and inflammation, facilitating the evaluation of novel therapeutic targets for asthma and other respiratory conditions. Lung-on-a-chip devices have been developed to replicate the physiological conditions of the human lung. The University of Michigan's "lung-on-a-chip" device uses human lung-tissue cells cultured on a plastic chip with microscopic channels to simulate the conditions inside the lungs, providing new insights into diseases. Thus, the increasing demand for effective treatments and research models fuels the growth of the in vitro lung model market.
In Vitro Lung Models Market Overview
Per the Centers for Disease Control and Prevention (CDC) data, asthma affected ~25 million people in the US in 2021. According to the WHO, in 2022, ~2.5 million individuals were diagnosed with lung cancer, and over 1.8 million people died from the disease. As per the WHO data, from the emergence of COVID-19 in late 2019 to April 2023, the number of reported cases was ~762 million, with 6.81 million associated deaths. This rising incidence of respiratory diseases is spurring the demand for advanced research models to understand disease mechanisms and develop effective treatments. In vitro lung models provide valuable platforms for studying disease mechanisms and testing potential therapies, supporting the development of effective treatments.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
In Vitro Lung Models Market: Strategic Insights
Market Size Value in US$ 185.80 Million in 2018 Market Size Value by US$ 701.81 Million by 2027 Growth rate CAGR of 16.2% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
In Vitro Lung Models Market: Strategic Insights
| Market Size Value in | US$ 185.80 Million in 2018 |
| Market Size Value by | US$ 701.81 Million by 2027 |
| Growth rate | CAGR of 16.2% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
In Vitro Lung Models Market Drivers and Opportunities
Rising Adoption of In Vitro Models as an Alternative to Animal Testing
In vitro lung models offer an alternative to animal testing, enabling researchers to study human lung biology and diseases with greater precision and relevance. These in vitro models closely replicate the alveoli, airways, vasculature, mesothelium, and interstitium of native lung tissue. Their multicellular composition allows for an accurate simulation of spatial and functional dynamics found in situ lungs, making them an indispensable tool in biomedical research. As a result, researchers are now adopting lung models for a wide range of applications, from disease modeling to toxicology and drug development. The 2021 Innovation grant spurred the development of a synthetic lung model at the University of Reading. The winner, Dr. Hisham Al-Obaidi, and his team at the University of Reading were awarded a US$ 8,692.19 (£6,500) Innovation Grant in 2021 to develop a synthetic lung model aimed at replacing animal testing. The project focuses on creating an in vitro lung model to evaluate the effectiveness of antimicrobial agents, with the goal of providing an in vitro model that resembles the human lungs to traditional animal-based methods. The team opted for a non-biological model designed to simulate drug behavior in the human respiratory system. Their approach demonstrated that the tested drug could penetrate deep into the lung-like structure, pass through a hydrogel layer simulating mucus, and eliminate bacterial presence. Now, the team is in the process of validating the model. This process includes testing the impact of inhaled antibiotic particles on mature bacterial colonies cultured on agar plates to determine whether any viable bacteria remain after treatment. This model could serve as a valuable tool for predicting antimicrobial efficacy in humans while reducing reliance on animal testing.
Surging Funding and Investments for In Vitro Models
In vitro lung models offer more accurate simulations of human lung physiology than traditional 2D cultures. This advancement has attracted investments from the public and private sectors. Emulate, a biotechnology company specializing in Organs-on-Chips technology, has attracted investments to commercialize human cell-based models that replicate organ-level functions. In September 2021, Emulate raised US$ 82 million in a Series E funding round led by the Founders Fund, underscoring the confidence in organ-on-chip platforms for drug testing and disease modeling. In December 2024, Newcells Biotech, a UK-based biotech startup specializing in the development of advanced in vitro models for drug discovery, secured US$ 1.60 million (£1.2 million) in funding from Mercia Ventures, Northstar Ventures, and North East Finance. Founded in 2015 as a spin-out from Newcastle University, Newcells develops 3D tissue models that replicate the retina, kidney, and lung. These models are used to predict drug safety and efficacy. The funding will enable Newcells to expand its customer base, form new partnerships, and enhance its offerings in key international markets. Thus, such funding and investments facilitate the development of more effective treatments for respiratory diseases, offering promising future opportunities for companies in the healthcare and biotechnology sectors.
In Vitro Lung Models Market Report Segmentation Analysis
Key segments that contributed to the derivation of the In Vitro Lung Models Market analysis are technology, animal type, route of administration, end user, and geography.
- Based on type, the In Vitro lung models market is bifurcated into 3D Models and 2D Models. The 3D model held the largest share of the In Vitro lung models market in 2024, and it is expected to register a significant CAGR during 2025–2031.
- By application, the market is categorized into drug discovery and toxicology studies, physiological research, regenerative medicine, and others. The drug discovery and toxicology studies segment held the largest share of the In Vitro lung models market in 2024.
- In terms of end user, the In Vitro lung models market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest share of the In Vitro lung models market in 2024, and it is expected to register a significant CAGR during 2025–2031.
In Vitro Lung Models Market Share Analysis by Geography
The geographic scope of the In Vitro Lung Models Market report is mainly divided into five major regions: North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America dominated the market in 2024. The technological innovations and strong biomedical research infrastructure contribute to the growth of the market in North America. Technological innovations have played a pivotal role in enhancing the complexity and functionality of in vitro models. Advancements in tissue engineering, microfluidics, and organ-on-a-chip technologies have enabled the development of more accurate and predictive models for drug discovery and toxicology studies. These innovations facilitate the creation of models that closely mimic human lung physiology, improving the reliability of preclinical testing and reducing the need for animal experiments.
The region is home to leading academic institutions, research organizations, and pharmaceutical companies that are at the forefront of in vitro lung modeling research. These institutions have access to state-of-the-art facilities, cutting-edge technologies, and skilled researchers, enabling them to innovate and advance the field. The market growth is also fueled by the presence of major industry players, the expansion of animal welfare programs and regulations, and a well-established healthcare infrastructure. Also, favorable government initiatives and a rising number of research collaborations further boost the growth of the In Vitro lung models market
In Vitro Lung Models Market Report Scope
In Vitro Lung Models Market News and Recent Developments
The In Vitro lung models market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Key developments in the market are listed below:
- Emulate, Inc., a provider of next-generation in vitro models, welcomed the U.S. Food and Drug Administration’s (FDA) newly announced plan to reduce reliance on animal testing in preclinical safety studies. The FDA’s strategic roadmap outlines how New Approach Methodologies (NAMs), including organ chips, advanced computational modeling, and other in vitro assays, will help streamline drug development, lower costs, and improve patient safety. (Source: Emulate Inc., Company Website, April 2025)
- Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, today announced it has signed an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Roche for US$ 1.2 billion. (Source: Lonza, Company Website, March 2025).
In Vitro Lung Models Market Report Coverage and Deliverables
The "In Vitro Lung Models Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- In Vitro Lung Models Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- In Vitro Lung Models Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- In Vitro Lung Models Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the In Vitro lung models Market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; Application and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
The surging prevalence of respiratory diseases and the rising adoption of in vitro models as an alternative to animal testing fuel the market growth.
North America dominated the market in 2024.
The application of 3D cultures and AI in oncology is expected to emerge as a prime trend in the market in the coming years.
MatTek Corp, Lonza Group AG, Emulate, Inc, CN Bio Innovations Ltd, PromoCell GmbH, Charles River Laboratories International Inc, MIMETAS BV, InSphero AG, Organovo Holdings Inc, Draper, Inc, Epithelix, AlveoliX AG, and American Type Culture Collection (ATCC) are among the key players in the market.
The market is expected to register a CAGR of 19.4% during 2025–2031.
The market value is expected to reach US$ 1,530.11 million by 2031.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. In-Vitro Lung Model Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Regulatory Scenario
5. In-Vitro Lung Model Market – Key Market Dynamics
5.1 In-Vitro Lung Model Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Surging Prevalence of Respiratory Diseases
5.2.2 Rising Adoption of In Vitro Models as an Alternative to Animal Testing
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
5.4.1 Surging Funding and Investments for In Vitro Models
5.5 Future Trends
5.5.1 Application of 3D Cultures and AI in Oncology
5.6 Impact of Drivers and Restraints:
6. In-Vitro Lung Model Market – Global Market Analysis
6.1 In-Vitro Lung Model Market Revenue (US$ Million), 2021–2031
6.2 In-Vitro Lung Model Market Forecast Analysis
7. In-Vitro Lung Model Market Analysis – by Type
7.1 3D Model
7.1.1 Overview
7.1.2 3D Model: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
7.2 2D Model
7.2.1 Overview
7.2.2 2D Model: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
8. In-Vitro Lung Model Market Analysis – by Application
8.1 Drug Discovery and Toxicology Studies
8.1.1 Overview
8.1.2 Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Physiological Research
8.2.1 Overview
8.2.2 Physiological Research: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Regenerative Medicine
8.3.1 Overview
8.3.2 Regenerative Medicine: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
9. In-Vitro Lung Model Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Academic and Research Institutes
9.2.1 Overview
9.2.2 Academic and Research Institutes: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
10. In-Vitro Lung Model Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America In-Vitro Lung Model Market Overview
10.2.2 North America: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
10.2.3 North America: In-Vitro Lung Model Market Breakdown, by Type
10.2.3.1 North America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Type
10.2.4 North America: In-Vitro Lung Model Market Breakdown, by Application
10.2.4.1 North America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Application
10.2.5 North America: In-Vitro Lung Model Market Breakdown, by End User
10.2.5.1 North America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by End User
10.2.6 North America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.2.1 United States: In-Vitro Lung Model Market Breakdown, by Type
10.2.6.2.2 United States: In-Vitro Lung Model Market Breakdown, by Application
10.2.6.2.3 United States: In-Vitro Lung Model Market Breakdown, by End User
10.2.6.3 Canada: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.3.1 Canada: In-Vitro Lung Model Market Breakdown, by Type
10.2.6.3.2 Canada: In-Vitro Lung Model Market Breakdown, by Application
10.2.6.4 Mexico: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.4.1 Mexico: In-Vitro Lung Model Market Breakdown, by Type
10.2.6.4.2 Mexico: In-Vitro Lung Model Market Breakdown, by Application
10.2.6.4.3 Mexico: In-Vitro Lung Model Market Breakdown, by End User
10.3 Europe
10.3.1 Europe In-Vitro Lung Model Market Overview
10.3.2 Europe: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
10.3.3 Europe: In-Vitro Lung Model Market Breakdown, by Type
10.3.3.1 Europe: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Type
10.3.4 Europe: In-Vitro Lung Model Market Breakdown, by Application
10.3.4.1 Europe: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Application
10.3.5 Europe: In-Vitro Lung Model Market Breakdown, by End User
10.3.5.1 Europe: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by End User
10.3.6 Europe: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.3.6.2 Germany: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.2.1 Germany: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.2.2 Germany: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.2.3 Germany: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.3 France: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.3.1 France: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.3.2 France: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.3.3 France: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.4 United Kingdom: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.4.1 United Kingdom: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.4.2 United Kingdom: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.4.3 United Kingdom: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.5 Italy: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.5.1 Italy: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.5.2 Italy: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.5.3 Italy: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.6 Spain: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.6.1 Spain: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.6.2 Spain: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.6.3 Spain: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.7 Rest of Europe: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.7.1 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.7.2 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: In-Vitro Lung Model Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific In-Vitro Lung Model Market Overview
10.4.2 Asia Pacific: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
10.4.3 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type
10.4.3.1 Asia Pacific: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Type
10.4.4 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application
10.4.4.1 Asia Pacific: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Application
10.4.4.2 Asia Pacific: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by End User
10.4.5 Asia Pacific: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.4.5.1 Asia Pacific: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.4.5.2 China: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.5.2.1 China: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.2.2 China: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.2.3 China: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.3 Japan: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.5.3.1 Japan: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.3.2 Japan: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.3.3 Japan: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.4 India: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.5.4.1 India: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.4.2 India: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.4.3 India: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.5 South Korea: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.5.5.1 South Korea: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.5.2 South Korea: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.5.3 South Korea: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.6 Australia: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.5.6.1 Australia: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.6.2 Australia: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.6.3 Australia: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.7 Rest of APAC: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.5.7.1 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.7.2 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.7.3 Rest of APAC: In-Vitro Lung Model Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa In-Vitro Lung Model Market Overview
10.5.2 Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
10.5.3 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
10.5.3.1 Middle East and Africa: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Type
10.5.4 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
10.5.4.1 Middle East and Africa: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Application
10.5.5 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
10.5.5.1 Middle East and Africa: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by End User
10.5.6 Middle East and Africa: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Middle East and Africa: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.5.6.2 Saudi Arabia: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.2.1 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Type
10.5.6.2.2 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Application
10.5.6.2.3 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by End User
10.5.6.3 South Africa: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.3.1 South Africa: In-Vitro Lung Model Market Breakdown, by Type
10.5.6.3.2 South Africa: In-Vitro Lung Model Market Breakdown, by Application
10.5.6.3.3 South Africa: In-Vitro Lung Model Market Breakdown, by End User
10.5.6.4 United Arab Emirates: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Type
10.5.6.4.2 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Application
10.5.6.4.3 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by End User
10.5.6.5 Rest of Middle East and Africa: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
10.5.6.5.2 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
10.5.6.5.3 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America In-Vitro Lung Model Market Overview
10.6.2 South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
10.6.3 South and Central America: In-Vitro Lung Model Market Breakdown, by Type
10.6.3.1 South and Central America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Type
10.6.4 South and Central America: In-Vitro Lung Model Market Breakdown, by Application
10.6.4.1 South and Central America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Application
10.6.5 South and Central America: In-Vitro Lung Model Market Breakdown, by End User
10.6.5.1 South and Central America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by End User
10.6.6 South and Central America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.6.6.1 South and Central America: In-Vitro Lung Model Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Brazil: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.2.1 Brazil: In-Vitro Lung Model Market Breakdown, by Type
10.6.6.2.2 Brazil: In-Vitro Lung Model Market Breakdown, by Application
10.6.6.2.3 Brazil: In-Vitro Lung Model Market Breakdown, by End User
10.6.6.3 Argentina: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.3.1 Argentina: In-Vitro Lung Model Market Breakdown, by Type
10.6.6.3.2 Argentina: In-Vitro Lung Model Market Breakdown, by Application
10.6.6.3.3 Argentina: In-Vitro Lung Model Market Breakdown, by End User
10.6.6.4 Rest of South and Central America: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Type
10.6.6.4.2 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Application
10.6.6.4.3 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 New Product Development
11.3 Merger and Acquisition
11.4 Partnerships and Collaborations
11.5 Other Business Strategies
12. Competitive Landscape
12.1 Global Company Market Share Analysis, 2024
13. Company Profiles
13.1 MatTek Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Lonza Group AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Emulate, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CN Bio Innovations Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Merck KGaA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 PromoCell GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.7 Charles River Laboratories InternationalInc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MIMETAS BV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 InSphero AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Organovo Holdings Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Draper, Inc.
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 TissUse GmbH
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.13 Epithelix
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Financial Overview
13.13.4 SWOT Analysis
13.13.5 Key Developments
13.14 AlveoliX AG
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 American Type Culture Collection (ATCC)
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
List of Tables
Table 1. In-Vitro Lung Model Market Segmentation
Table 2. In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million)
Table 3. In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 4. In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 5. In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 6. In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 7. In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 8. In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 9. In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 10. North America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 11. North America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 12. North America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 13. North America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 14. North America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 15. North America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 16. North America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 17. North America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 18. United States: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 19. United States: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 20. United States: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 21. United States: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 22. United States: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 23. United States: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 24. Canada: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 25. Canada: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 26. Canada: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 27. Canada: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 28. Mexico: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 29. Mexico: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 30. Mexico: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 31. Mexico: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 32. Mexico: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 33. Mexico: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 34. Europe: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 35. Europe: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 36. Europe: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 37. Europe: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 38. Europe: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 39. Europe: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 40. Europe: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 41. Europe: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 42. Germany: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 43. Germany: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 44. Germany: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 45. Germany: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 46. Germany: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 47. Germany: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 48. France: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 49. France: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 50. France: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 51. France: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 52. France: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 53. France: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 54. United Kingdom: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 55. United Kingdom: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 56. United Kingdom: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 57. United Kingdom: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 58. United Kingdom: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 59. United Kingdom: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 60. Italy: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 61. Italy: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 62. Italy: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 63. Italy: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 64. Italy: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 65. Italy: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 66. Spain: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 67. Spain: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 68. Spain: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 69. Spain: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 70. Spain: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 71. Spain: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 72. Rest of Europe: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 73. Rest of Europe: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 74. Rest of Europe: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 75. Rest of Europe: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 76. Rest of Europe: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 77. Rest of Europe: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 78. Asia Pacific: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 79. Asia Pacific: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 80. Asia Pacific: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 81. Asia Pacific: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 82. Asia Pacific: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 83. Asia Pacific: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 84. Asia Pacific: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 85. Asia Pacific: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 86. China: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 87. China: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 88. China: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 89. China: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 90. China: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 91. China: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 92. Japan: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 93. Japan: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 94. Japan: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 95. Japan: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 96. Japan: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 97. Japan: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 98. India: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 99. India: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 100. India: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 101. India: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 102. India: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 103. India: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 104. South Korea: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 105. South Korea: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 106. South Korea: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 107. South Korea: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 108. South Korea: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 109. South Korea: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 110. Australia: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 111. Australia: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 112. Australia: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 113. Australia: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 114. Australia: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 115. Australia: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 116. Rest of APAC: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 117. Rest of APAC: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 118. Rest of APAC: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 119. Rest of APAC: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 120. Rest of APAC: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 121. Rest of APAC: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 122. Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 123. Middle East and Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 124. Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 125. Middle East and Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 126. Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 127. Middle East and Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 128. Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 129. Middle East and Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 130. Saudi Arabia: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 131. Saudi Arabia: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 132. Saudi Arabia: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 133. Saudi Arabia: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 134. Saudi Arabia: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 135. Saudi Arabia: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 136. South Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 137. South Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 138. South Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 139. South Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 140. South Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 141. South Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 142. United Arab Emirates: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 143. United Arab Emirates: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 144. United Arab Emirates: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 145. United Arab Emirates: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 146. United Arab Emirates: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 147. United Arab Emirates: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 148. Rest of Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 149. Rest of Middle East and Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 150. Rest of Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 151. Rest of Middle East and Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 152. Rest of Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 153. Rest of Middle East and Africa: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 154. South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 155. South and Central America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 156. South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 157. South and Central America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 158. South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 159. South and Central America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 160. South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 161. South and Central America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 162. Brazil: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 163. Brazil: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 164. Brazil: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 165. Brazil: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 166. Brazil: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 167. Brazil: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 168. Argentina: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 169. Argentina: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 170. Argentina: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 171. Argentina: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 172. Argentina: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 173. Argentina: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 174. Rest of South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 175. Rest of South and Central America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 176. Rest of South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 177. Rest of South and Central America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 178. Rest of South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 179. Rest of South and Central America: In-Vitro Lung Model Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 180. Glossary of Terms, In-Vitro Lung Model Market
List of Figures
Figure 1. In-Vitro Lung Model Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. In-Vitro Lung Model Market Revenue (US$ Million), 2021–2031
Figure 5. In-Vitro Lung Model Market Share (%) – by Type (2024 and 2031)
Figure 6. 3D Model: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. 2D Model: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. In-Vitro Lung Model Market Share (%) – by Application (2024 and 2031)
Figure 9. Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Physiological Research: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regenerative Medicine: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. In-Vitro Lung Model Market Share (%) – by End User (2024 and 2031)
Figure 14. Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Academic and Research Institutes: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: In-Vitro Lung Model Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. In-Vitro Lung Model Market Breakdown by Region, 2024 and 2031 (%)
Figure 18. North America: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
Figure 19. North America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 20. North America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 21. North America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
Figure 22. North America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 23. United States: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 24. Canada: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 25. Mexico: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 26. Europe: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
Figure 27. Europe: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 28. Europe: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 29. Europe: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
Figure 30. Europe: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 31. Germany: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 32. France: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 33. United Kingdom: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 34. Italy: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 35. Spain: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 36. Rest of Europe: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 37. Asia Pacific: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
Figure 38. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 39. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 40. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 41. China: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 42. Japan: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 43. India: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 44. South Korea: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 45. Australia: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 46. Rest of APAC: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 47. Middle East and Africa: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
Figure 48. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 49. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 50. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
Figure 51. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 52. Saudi Arabia: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 53. South Africa: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 54. United Arab Emirates: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 55. Rest of Middle East and Africa: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 56. South and Central America: In-Vitro Lung Model Market – Revenue, 2021–2031 (US$ Million)
Figure 57. South and Central America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 58. South and Central America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 59. South and Central America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
Figure 60. South and Central America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 61. Brazil: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 62. Argentina: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 63. Rest of South and Central America: In-Vitro Lung Model Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 64. Global Company Market Share Analysis, 2024
List of Companies - In Vitro Lung Models Market
- MatTek Corp
- Lonza Group AG
- Emulate, Inc
- CN Bio Innovations Ltd
- PromoCell GmbH
- Charles River Laboratories International Inc
- MIMETAS BV
- InSphero AG
- Organovo Holdings Inc
- Draper, Inc
- Epithelix, AlveoliX AG
- American Type Culture Collection (ATCC)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to In Vitro Lung Models Market
Jun 2025
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Jun 2025
Pediatric Cardiology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Transcatheter Heart Valves, Occlusion Devices, Catheters, Stents, Introducer Sheaths, and Others), Disease Indication (Congenital Heart Disease, Acquired Heart Disease, Arrhythmias, Cardiomyopathies, and Others), Surgical Procedure (Interventional Procedures, Heart Rhythm Management Procedures, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2025
Pharmaceutical Membrane Filters Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Microfiltration, Ultrafiltration, Reverse Osmosis and Nanofiltration), Design (Hollow Fiber, Spiral Wound, Tubular System and Plate and Frame), Material (Polyethersulfone (PES), Polysulfone (PS), Cellulose-Based Membranes, Polytetrafluoroethylene (PTFE), Polyvinyl Chloride (PVC), Polyacrylonitrile (PAN) and Others), End User (Pharmaceutical and Biotech Industries and CROs and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
Jun 2025
ECG Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG and Stress ECG), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2025
Surgical Laser Fiber Units Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (CO2 Laser, Diode Laser, Erbium Laser, Nd:YAG Laser, Holmium Laser, Alexandrite Laser, and Others), Material (Silica-Based Fibers, Quartz Fibers, Polymer-Based Fibers, Multimode Fibers, and Others), Power (Low-Power Lasers, Medium-Power Lasers, and High-Power Lasers), Application (Urology, Dermatology, Gynecology, Cardiology, Neurology, Ophthalmology, Respiratory, Dentistry and Others), Wavelength (9,301 nm and above, 2,941–9,300 nm, and 1,441–2,940 nm, 821–1,440 nm, 710–820 nm, and below 710 nm), End User (Hospitals, Specialty Clinics, Physician Office, and Others), and Geography
Jun 2025
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography
Jun 2025
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography
Jun 2025
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)